Apogee Therapeutics, Inc. - Common Stock (NQ:APGE)
134.29
+0.21
(+0.16%)
Streaming Delayed Price
Updated: 11:34 AM EDT, Jul 23, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 288,065 |
| Open | 134.11 |
| Bid (Size) | 134.29 (400) |
| Ask (Size) | 134.30 (600) |
| Prev. Close | 134.08 |
| Today's Range | 134.02 - 134.33 |
| 52wk Range | 34.34 - 134.40 |
| Shares Outstanding | 56,367,802 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
My 2 Favorite Dividend Kings to Buy Right Now ↗
July 19, 2026
The Dividend ETF Quietly Outperforming the S&P 500 ↗
July 07, 2026
Why AbbVie Stock Jumped Today ↗
June 22, 2026
Which stocks are moving on Monday? ↗
June 22, 2026
Monday's session: gap up and gap down stocks ↗
June 22, 2026
Frequently Asked Questions
Is Apogee Therapeutics, Inc. - Common Stock publicly traded?
Yes, Apogee Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Apogee Therapeutics, Inc. - Common Stock trade on?
Apogee Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Apogee Therapeutics, Inc. - Common Stock?
The ticker symbol for Apogee Therapeutics, Inc. - Common Stock is APGE on the Nasdaq Stock Market
What is the current price of Apogee Therapeutics, Inc. - Common Stock?
The current price of Apogee Therapeutics, Inc. - Common Stock is 134.29
When was Apogee Therapeutics, Inc. - Common Stock last traded?
The last trade of Apogee Therapeutics, Inc. - Common Stock was at 07/23/26 11:34 AM ET
What is the market capitalization of Apogee Therapeutics, Inc. - Common Stock?
The market capitalization of Apogee Therapeutics, Inc. - Common Stock is 7.57B
How many shares of Apogee Therapeutics, Inc. - Common Stock are outstanding?
Apogee Therapeutics, Inc. - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
